The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 1222341)

Published in Biochem J on February 01, 2002

Authors

James A Mahoney1, Joseph A Odin, Sarah M White, David Shaffer, Andrew Koff, Livia Casciola-Rosen, Antony Rosen

Author Affiliations

1: Department of Medicine, The Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, USA. jmahoney@jhmi.edu

Articles cited by this

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 16.08

A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem (1997) 9.97

Programmed cell death in animal development. Cell (1997) 8.95

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21

A proteolytic pathway that recognizes ubiquitin as a degradation signal. J Biol Chem (1995) 7.79

A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell (1999) 6.04

Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ (1999) 5.35

A matter of life and cell death. Science (1998) 5.33

Substrate specificities of caspase family proteases. J Biol Chem (1997) 4.16

U box proteins as a new family of ubiquitin-protein ligases. J Biol Chem (2001) 3.70

Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature (1995) 3.59

Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem (1998) 2.93

Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med (1999) 2.81

The U box is a modified RING finger - a common domain in ubiquitination. Curr Biol (2000) 2.73

DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med (1995) 2.25

Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell (2000) 1.98

Caspases: preparation and characterization. Methods (1999) 1.92

Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J Exp Med (2000) 1.89

Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity (1998) 1.88

Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem (1999) 1.87

Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax. J Exp Med (2000) 1.73

Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem (1998) 1.65

Mitochondria-dependent and -independent regulation of Granzyme B-induced apoptosis. J Exp Med (1999) 1.31

Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition. J Biol Chem (2000) 1.15

Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett (1996) 1.09

A novel component involved in ubiquitination is required for development of Dictyostelium discoideum. J Biol Chem (1998) 1.02

Apoptosis genes and autoimmunity. Curr Opin Immunol (2000) 1.01

Caspase-mediated proteolysis during apoptosis: insights from apoptotic neutrophils. FEBS Lett (1998) 0.96

Granzyme B. Methods Enzymol (1994) 0.90

Articles by these authors

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature (2005) 15.83

Suicide prevention strategies: a systematic review. JAMA (2005) 14.79

Youth suicide risk and preventive interventions: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry (2003) 5.69

p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell (2009) 4.30

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum (2011) 2.99

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med (2005) 2.82

CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis. Mol Cell (2009) 2.79

Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity. Sci Transl Med (2013) 2.51

Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci Transl Med (2013) 2.51

Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science (2013) 2.46

Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry (2003) 2.40

Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08

Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res (Hoboken) (2010) 1.99

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Arch Gen Psychiatry (2006) 1.93

Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. J Biol Chem (2002) 1.88

Polyclonal antibody-induced serum sickness in renal transplant recipients: treatment with therapeutic plasma exchange. Transplantation (2005) 1.84

National trends in hospitalization of youth with intentional self-inflicted injuries. Am J Psychiatry (2005) 1.80

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol (2011) 1.80

Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med (2002) 1.78

Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol (2010) 1.73

Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum (2005) 1.67

Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet (2010) 1.62

Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res (2004) 1.57

Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. Arthritis Rheum (2010) 1.54

Apoptotic cell blebs: repositories of autoantigens and contributors to immune context. Arthritis Rheum (2009) 1.53

Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss. Arthritis Rheum (2002) 1.53

Suicide attempt characteristics, diagnoses, and future attempts: comparing multiple attempters to single attempters and ideators. J Am Acad Child Adolesc Psychiatry (2008) 1.52

Pre-transplant overweight and obesity do not affect physical quality of life after kidney transplantation. J Am Coll Surg (2010) 1.51

ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology (2006) 1.49

Hdm2- and proteasome-dependent turnover limits p21 accumulation during S phase. Cell Cycle (2011) 1.49

Adolescent depression screening in primary care: feasibility and acceptability. Pediatrics (2007) 1.48

Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum (2008) 1.48

Emergency treatment of young people following deliberate self-harm. Arch Gen Psychiatry (2005) 1.47

Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis (2011) 1.45

Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43

Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum (2010) 1.39

p27 as a target for cancer therapeutics. Cancer Cell (2003) 1.38

Living-related transplantation of an ectopic pelvic kidney. Transplantation (2004) 1.35

Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheumatol (2008) 1.32

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet (2012) 1.32

Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle. Arthritis Rheum (2009) 1.31

A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM). J Neurooncol (2008) 1.31

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. Arthritis Rheum (2013) 1.27

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry (2010) 1.27

Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications. Curr Opin Rheumatol (2011) 1.26

Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest (2009) 1.25

Apoptosis and autoimmunity. Curr Opin Immunol (2005) 1.25

Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res (Hoboken) (2013) 1.24

Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Arthritis Rheum (2010) 1.23

Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin. J Biol Chem (2002) 1.22

Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. FASEB J (2006) 1.19

Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses. Immunology (2010) 1.18

Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum (2007) 1.17

The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior. Cell Cycle (2009) 1.13

Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J Biol Chem (2002) 1.12

Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol (2003) 1.11

Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. J Child Adolesc Psychopharmacol (2003) 1.10

Substance use, suicidal ideation and attempts in children and adolescents. Suicide Life Threat Behav (2004) 1.10

Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc Natl Acad Sci U S A (2012) 1.10

Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). EMBO J (2007) 1.10

Altered structure of autoantigens during apoptosis. Rheum Dis Clin North Am (2004) 1.09

Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition. EMBO J (2007) 1.09

Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway. J Biol Chem (2006) 1.08

Cholestatic liver injury associated with whey protein and creatine supplements. Semin Liver Dis (2008) 1.08

PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. J Biol Chem (2005) 1.07

Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors. Mol Biol Cell (2005) 1.07

The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2. Mol Cell Biol (2006) 1.07

Noncatalytic requirement for cyclin A-cdk2 in p27 turnover. Mol Cell Biol (2004) 1.06

Apoptosis in systemic lupus erythematosus. Curr Opin Rheumatol (2003) 1.05

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05

Interweaving the cell cycle machinery with cell differentiation. Cell Cycle (2007) 1.04

Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci U S A (2003) 1.03

SSRI prescriptions and the rate of suicide. Am J Psychiatry (2007) 1.03

T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun (2007) 1.03

A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature. Medicine (Baltimore) (2012) 1.03

Anti-aminoacyl tRNA synthetase immune responses: insights into the pathogenesis of the idiopathic inflammatory myopathies. Curr Opin Rheumatol (2003) 1.01

Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol (2009) 1.01

Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate. Proc Natl Acad Sci U S A (2004) 0.98

School-based screening to identify at-risk students not already known to school professionals: the Columbia suicide screen. Am J Public Health (2008) 0.98

Sexual dimorphism in immune response genes as a function of puberty. BMC Immunol (2006) 0.98

The test-retest reliability and screening efficiency of DISC Predictive Scales-version 4.32 (DPS-4.32) with Chinese children/youths. Eur Child Adolesc Psychiatry (2005) 0.98

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry (2010) 0.98

p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development. Oncogene (2003) 0.97

Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology (2004) 0.97

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. Arthritis Rheum (2008) 0.96

p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia. Gastroenterology (2007) 0.96

Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. Arthritis Rheum (2003) 0.96